132 related articles for article (PubMed ID: 36685670)
21. A 4K score/MRI-based nomogram for predicting prostate cancer, clinically significant prostate cancer, and unfavorable prostate cancer.
Wagaskar VG; Sobotka S; Ratnani P; Young J; Lantz A; Parekh S; Falagario UG; Li L; Lewis S; Haines K; Punnen S; Wiklund P; Tewari A
Cancer Rep (Hoboken); 2021 Aug; 4(4):e1357. PubMed ID: 33661541
[TBL] [Abstract][Full Text] [Related]
22. Developing a nomogram based on multiparametric magnetic resonance imaging for forecasting high-grade prostate cancer to reduce unnecessary biopsies within the prostate-specific antigen gray zone.
Niu XK; Li J; Das SK; Xiong Y; Yang CB; Peng T
BMC Med Imaging; 2017 Feb; 17(1):11. PubMed ID: 28143433
[TBL] [Abstract][Full Text] [Related]
23. Multicenter European external validation of a prostate health index-based nomogram for predicting prostate cancer at extended biopsy.
Lughezzani G; Lazzeri M; Haese A; McNicholas T; de la Taille A; Buffi NM; Fossati N; Lista G; Larcher A; Abrate A; Mistretta A; Bini V; Palou Redorta J; Graefen M; Guazzoni G
Eur Urol; 2014 Nov; 66(5):906-12. PubMed ID: 24361258
[TBL] [Abstract][Full Text] [Related]
24. A novel nomogram to identify candidates for active surveillance amongst patients with International Society of Urological Pathology (ISUP) Grade Group (GG) 1 or ISUP GG2 prostate cancer, according to multiparametric magnetic resonance imaging findings.
Luzzago S; de Cobelli O; Cozzi G; Peveri G; Bagnardi V; Catellani M; Di Trapani E; Mistretta FA; Pricolo P; Conti A; Alessi S; Marvaso G; Ferro M; Matei DV; Renne G; Jereczek-Fossa BA; Petralia G; Musi G
BJU Int; 2020 Jul; 126(1):104-113. PubMed ID: 32150328
[TBL] [Abstract][Full Text] [Related]
25. Performing Precise Biopsy in Naive Patients With Equivocal PI-RADS, Version 2, Score 3, Lesions: An MRI-based Nomogram to Avoid Unnecessary Surgical Intervention.
Zhang Y; Zeng N; Zhang FB; Rui Huang YX; Tian Y
Clin Genitourin Cancer; 2020 Oct; 18(5):367-377. PubMed ID: 32771334
[TBL] [Abstract][Full Text] [Related]
26. Development and validation of a nomogram for predicting prostate cancer in patients with PSA ≤ 20 ng/mL at initial biopsy.
Wu Q; Li F; Yin X; Gao J; Zhang X
Medicine (Baltimore); 2021 Dec; 100(50):e28196. PubMed ID: 34918677
[TBL] [Abstract][Full Text] [Related]
27. The prediction value of PI-RADS v2 score in high-grade Prostate Cancer: a multicenter retrospective study.
Chen S; Yang Y; Peng T; Yu X; Deng H; Guo Z
Int J Med Sci; 2020; 17(10):1366-1374. PubMed ID: 32624693
[No Abstract] [Full Text] [Related]
28. Development and validation of a multi-parameter nomogram for predicting prostate cancer: a retrospective analysis from Handan Central Hospital in China.
Nan L; Guo K; Li M; Wu Q; Huo S
PeerJ; 2022; 10():e12912. PubMed ID: 35256916
[TBL] [Abstract][Full Text] [Related]
29. The stanford prostate cancer calculator: Development and external validation of online nomograms incorporating PIRADS scores to predict clinically significant prostate cancer.
Wang NN; Zhou SR; Chen L; Tibshirani R; Fan RE; Ghanouni P; Thong AE; To'o KJ; Ghabili K; Nix JW; Gordetsky JB; Sprenkle P; Rais-Bahrami S; Sonn GA
Urol Oncol; 2021 Dec; 39(12):831.e19-831.e27. PubMed ID: 34247909
[TBL] [Abstract][Full Text] [Related]
30. Development and Internal Validation of Novel Nomograms Based on Benign Prostatic Obstruction-Related Parameters to Predict the Risk of Prostate Cancer at First Prostate Biopsy.
Cormio L; Cindolo L; Troiano F; Marchioni M; Di Fino G; Mancini V; Falagario U; Selvaggio O; Sanguedolce F; Fortunato F; Schips L; Carrieri G
Front Oncol; 2018; 8():438. PubMed ID: 30386737
[TBL] [Abstract][Full Text] [Related]
31. Development and validation of a nomogram including lymphocyte-to-monocyte ratio for initial prostate biopsy: a double-center retrospective study.
Zhou ZH; Liu F; Wang WJ; Liu X; Sun LJ; Zhu Y; Ye DW; Zhang GM
Asian J Androl; 2021; 23(1):41-46. PubMed ID: 32503957
[TBL] [Abstract][Full Text] [Related]
32. A nomogram based on age, prostate-specific antigen level, prostate volume and digital rectal examination for predicting risk of prostate cancer.
Tang P; Chen H; Uhlman M; Lin YR; Deng XR; Wang B; Yang WJ; Xie KJ
Asian J Androl; 2013 Jan; 15(1):129-33. PubMed ID: 23291910
[TBL] [Abstract][Full Text] [Related]
33. [Developing a Chinese PI-RADS v2-based nomogram for predicting clinically significant prostate cancer in patients with a prior negative biopsy].
Huang C; Song G; Wang H; Ji GJ; Chen YK; He Q; Zhou LQ
Zhonghua Yi Xue Za Zhi; 2018 Aug; 98(32):2559-2563. PubMed ID: 30220139
[No Abstract] [Full Text] [Related]
34. Prediction nomogram for
Ceci F; Bianchi L; Borghesi M; Polverari G; Farolfi A; Briganti A; Schiavina R; Brunocilla E; Castellucci P; Fanti S
Eur J Nucl Med Mol Imaging; 2020 Jan; 47(1):136-146. PubMed ID: 31492993
[TBL] [Abstract][Full Text] [Related]
35. The roles of prostate-specific antigen (PSA) density, prostate volume, and their zone-adjusted derivatives in predicting prostate cancer in patients with PSA less than 20.0 ng/mL.
Shen P; Zhao J; Sun G; Chen N; Zhang X; Gui H; Yang Y; Liu J; Shu K; Wang Z; Zeng H
Andrology; 2017 May; 5(3):548-555. PubMed ID: 28409907
[TBL] [Abstract][Full Text] [Related]
36. Development and validation of a predictive model for determining clinically significant prostate cancer in men with negative magnetic resonance imaging after transrectal ultrasound-guided prostate biopsy.
Liu G; Zhu Y; Yao Z; Jiang Y; Wu B; Bai S
Prostate; 2021 Sep; 81(13):983-991. PubMed ID: 34254330
[TBL] [Abstract][Full Text] [Related]
37. Prostate-specific antigen nomogram to predict advanced prostate cancer using area under the receiver operating characteristic curve boosting.
Hashimoto T; Komori O; Nakashima J; Kashima T; Yamaguchi Y; Satake N; Nakagami Y; Shishido T; Namiki K; Ohno Y
Urol Oncol; 2022 Apr; 40(4):162.e9-162.e16. PubMed ID: 35065881
[TBL] [Abstract][Full Text] [Related]
38. [Development of a Chinese nomogram based on muti-parametric magnetic resonance for predicting the probability of prostate cancer in patients after initial negative biopsy].
Huang C; Ji GJ; Song G; Wang H; Chen YK; Zhou LQ
Zhonghua Yi Xue Za Zhi; 2018 Jan; 98(2):132-135. PubMed ID: 29343039
[No Abstract] [Full Text] [Related]
39. Development and Validation of a Radiomics Nomogram for Predicting Clinically Significant Prostate Cancer in PI-RADS 3 Lesions.
Li T; Sun L; Li Q; Luo X; Luo M; Xie H; Wang P
Front Oncol; 2021; 11():825429. PubMed ID: 35155214
[TBL] [Abstract][Full Text] [Related]
40. Nomogram predicting prostate cancer in patients with negative prebiopsy multiparametric magnetic resonance.
Chen M; Wang R; Zhang T; Zhang X; Wan Y; Fu X
Future Oncol; 2022 Apr; 18(12):1473-1483. PubMed ID: 35105154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
